title: Psychiatric consultation for post-liver-transplantation patients.
abstract: OBJECTIVE
  This report describes the clinical characteristics of referral inpatients who received liver transplantation and the surgeon's concordance with the psychiatric consultation.
  
  
  METHODS
  During a 4-year period, psychiatric consultation was arranged for 30 post-liver-transplantation inpatients at Kaohsiung Chang Gung Memorial Hospital. A psychiatrist assessed these patients and made psychiatric diagnoses according to the Diagnostic and Statistical Manual, 4th edition. The clinical data were routinely collected via modified MICRO-CARES software. At the end of the 4-year study period, all the medical records of these 30 inpatients were reviewed.
  
  
  RESULTS
  Psychiatric diagnosis was made in 70% of the patients (n = 21) in three major categories, including delirious state (n = 8), depressive disorder (n = 5), and anxiety/dyssomnia (n = 8). All these conditions were improved by psychiatric management. We found that the consultee's concordance with recommended drug prescriptions was high with antidepressants in depressive patients and low with antipsychotics in patients with delirium. Moreover, anxiolytics were frequently prescribed in post-transplant inpatients before psychiatric consultation.
  
  
  CONCLUSIONS
  These findings suggest that psychiatric consultation is beneficial to inpatients after liver transplantation, especially those with depression and delirium.
authors.affiliation: Department of Psychiatry, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan. neinmuch@cgmh.org.tw
authors.forename: Nien-Mu
authors.initials: NM
authors.lastname: Chiu
authors.forename: Chao-Long
authors.initials: CL
authors.lastname: Chen
authors.forename: Andrew T A
authors.initials: AT
authors.lastname: Cheng
mesh_terms: D000328:Adult; D000368:Aged; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D003693:Delirium / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D003866:Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D011307:Drug Prescriptions / Q000706:statistics & numerical data; D020920:Dyssomnias / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D005260:Female; D006760:Hospitalization; D006801:Humans; D016031:Liver Transplantation / Q000523:psychology*; D008137:Longitudinal Studies; D008297:Male; D001523:Mental Disorders / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D008875:Middle Aged; D011567:Psychiatric Department, Hospital / Q000706:statistics & numerical data*; D011569:Psychiatric Status Rating Scales / Q000706:statistics & numerical data; D011570:Psychiatry; D012017:Referral and Consultation; D013624:Taiwan / Q000453:epidemiology
chemical_list: D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D014150:Antipsychotic Agents